Effects of GLP-1 RAs on gut microbiota: preclinical and clinical evidence The gut microbiota plays a central role in metabolic regulation, particularly in lipid and energy homeostasis, and its alteration is increasingly recognized as a risk factor for obesity, T2D and cardiovascular disease ( Bacillota (formerly Firmicutes ), Bacteroidota (formerly Bacteroidetes) , and Proteobacteria , with obesity-associated patterns often reflecting decreased microbial diversity and loss of beneficial taxa ( Given this evidence, targeting the gut microbiota has emerged as a potential strategy for preventing or ameliorating metabolic diseases, including T2D and dyslipidemia ( Bacillota and Bacteroidota , may influence insulin sensitivity partly through modulation of GLP-1 secretion
Data were independently extracted by two reviewers into a standardized spreadsheet, and pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random-effects model
Obesity, liver disease, and AUD often go together
Domina la distanciaFotografa telemacroCaptura detalles asombrosos de objetos pequeos con una distancia mnima de enfoque de 30cm
What glutathione does is reduce the formation of melanin and hence gives a fair complexion to our skin
Dihexa , a new and innovative kind of peptide, has been shown to have the potential to restore cognitive ability, improve memory, and promote the creation of new synaptic connections in the brain, which may be able to aid those who suffer from issues or disorders of the brain and help them to regain their mental capacity